VRNA - Verona Pharma plc

Healthcare - Sector
Coverage Rating Distribution Performance Price Targets & Ratings Chart

VRNA is currently covered by 4 analysts with average potential upside of $10.83 (112.2%) backed by 5 price targets and 15 ratings. Documented since 22-May-2017. Analyst's average stock valuation to be materialised ratio is 66.67% with an average time for price targets to be met of 611.5 days.

Most recent stock forecast was given by THOMAS SHRADER from BTIG on 20-Mar-2023.

Highest price target for VRNA is 23, Lowest price target is 4, average price target is 13.5.

Best performing analysts who are covering VRNA - Verona Pharma plc:

Liana Moussatos Edward Nash Thomas Shrader Raghuram Selvaraju

Currently, out of the existing stock ratings of VRNA - 10 which are a Buy (100%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

31

$10.37 (50.27%)

26

5 days ago

2/3 (66.67%)

$8.58 (47.82%)

1025

Buy

32

$11.37 (55.11%)

32

12 days ago

0/2 (0%)

$10.97 (53.77%)

Buy

23

$2.37 (11.49%)

18

7 months 16 days ago

3/3 (100%)

$12.06 (173.05%)

790

Buy

23

$2.37 (11.49%)

18

1 years 4 months 13 days ago

4/4 (100%)

$11.72 (174.15%)

631

Show more analysts

What is VRNA(Verona Pharma plc) average time for price targets to be met?

On average it took 611.5 days on average for the stock forecasts to be realized with a an average price target met ratio 66.67

Which analyst has the current highest performing score on VRNA(Verona Pharma plc) with a proven track record?

LIANA MOUSSATOS